Literature DB >> 7003298

The acute monocytic leukemias: multidisciplinary studies in 45 patients.

D J Straus, R Mertelsmann, B Koziner, S McKenzie, E de Harven, Z A Arlin, S Kempin, H Broxmeyer, M A Moore, C J Menendez-Botet, T S Gee, B D Clarkson.   

Abstract

The clinical and laboratory features of 37 patients with variants of acute monocytic leukemia are described. Three of these 37 patients who had extensive extramedullary leukemic tissue infiltration are examples of true histiocytic "lymphomas." Three additional patients with undifferentiated leukemias, one patient with refractory anemia with excess of blasts, one patient with chronic myelomonocytic leukemia, one patient with B-lymphocyte diffuse "histiocytic" lymphoma and one patient with "null" cell, terminal deoxynucleotidyl transferase-positive lymphoblastic lymphoma had bone marrow cells with monocytic features. Another patient had dual populations of lymphoid and monocytoid leukemic cells. The true monocytic leukemias, acute monocytic leukemia (AMOL) and acute myelomonocytic leukemia (AMMOL), are closely related to acute myelocytic leukemia (AML) morphologically and by their response to chemotherapy. like AML, the leukemic cells from the AMMOL and AMOL patients form leukemic clusters in semisolid media. Cytochemical staining of leukemic cells for nonspecific esterases, presence of Fc receptor on the cell surface, phagocytic ability, low TdT activity, presence of surface "ruffles" and "ridges" on scanning EM, elevations of serum lysozyme, and clinical manifestations of leukemic tissue infiltration are features which accompanied monocytic differentiation in these cases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7003298     DOI: 10.1097/00005792-198011000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  8 in total

1.  Acute myelomonocytic leukaemia presenting as xanthomatous skin eruption.

Authors:  J R O'Donnell; P Tansey; P Chung; A K Burnett; J Thomson; G A McDonald
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

2.  Serum enzyme concentrations in untreated acute myeloid leukaemia.

Authors:  C S Scott; M Davey; A Hamilton; D R Norfolk
Journal:  Blut       Date:  1986-05

3.  Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development.

Authors:  Xun Gui; Mi Deng; Hao Song; Yuanzhi Chen; Jingjing Xie; Zunling Li; Licai He; Fangfang Huang; Yixiang Xu; Yasuaki Anami; Hai Yu; Chenyi Yu; Leike Li; Zihao Yuan; Xiaoying Xu; Qihui Wang; Yan Chai; Tao Huang; Yi Shi; Kyoji Tsuchikama; X Charlene Liao; Ningshao Xia; George F Gao; Ningyan Zhang; Cheng Cheng Zhang; Zhiqiang An
Journal:  Cancer Immunol Res       Date:  2019-06-18       Impact factor: 11.151

Review 4.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

5.  Cutaneous herald: leukaemia cutis as presenting manifestation of relapse in acute promyelocytic leukaemia.

Authors:  Prasanth Balasubramanian; Ram V Nampoothiri; Deepak Goni; Pankaj Malhotra
Journal:  BMJ Case Rep       Date:  2018-05-02

6.  Lymphoma-like presentation of acute monocytic leukaemia.

Authors:  B Bain; A Manoharan; I Lampert; C McKenzie; D Catovsky
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

7.  Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.

Authors:  Judith E Karp; Amanda Blackford; B Douglas Smith; Katrina Alino; Amy Hatfield Seung; Javier Bolaños-Meade; Jacqueline M Greer; Hetty E Carraway; Steven D Gore; Richard J Jones; Mark J Levis; Michael A McDevitt; L Austin Doyle; John J Wright
Journal:  Leuk Res       Date:  2009-12-04       Impact factor: 3.156

8.  LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration.

Authors:  Mi Deng; Xun Gui; Jaehyup Kim; Li Xie; Weina Chen; Zunling Li; Licai He; Yuanzhi Chen; Heyu Chen; Weiguang Luo; Zhigang Lu; Jingjing Xie; Hywyn Churchill; Yixiang Xu; Zhan Zhou; Guojin Wu; Chenyi Yu; Samuel John; Kouyuki Hirayasu; Nam Nguyen; Xiaoye Liu; Fangfang Huang; Leike Li; Hui Deng; Haidong Tang; Ali H Sadek; Lingbo Zhang; Tao Huang; Yizhou Zou; Benjamin Chen; Hong Zhu; Hisashi Arase; Ningshao Xia; Youxing Jiang; Robert Collins; M James You; Jade Homsi; Nisha Unni; Cheryl Lewis; Guo-Qiang Chen; Yang-Xin Fu; X Charlene Liao; Zhiqiang An; Junke Zheng; Ningyan Zhang; Cheng Cheng Zhang
Journal:  Nature       Date:  2018-10-17       Impact factor: 49.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.